ArticleHeliyon2022
Creating standards for Canadian health data protection during health emergency - An analysis of privacy regulations and laws.
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Experiences and Challenges of Patients With Chronic Respiratory Disease During a Virtual Research Study: Qualitative Study.Journal of participatory medicine · 2026Article
- Standardizing Health Workforce Data in Canada: Legal and Regulatory Levers for Harmonized Collection and Sharing.Healthcare management forum · 2026Article
- Information Source Characteristics of Personal Data Leakage During the COVID-19 Pandemic in China: Observational Study.JMIR medical informatics · 2024Observational
- Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific research.Insights into imaging · 2024Review
- Sufficiency for PSS tracking gait disorders in multiple sclerosis: A managerial perspective.Heliyon · 2024Article
- Health data governance for research use in Alberta.International journal of population data science · 2023Article
- Editorial: The use of real world data for regulatory purposes in the rare diseases setting.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health emergencies require unprecedented measures to protect the public from the health disaster. Such measures may require limiting the exercise of personal freedom and other rights like the right to data privacy. The limitation, however, should be temporary and proportionate so that privacy rights are not compromised superfluously. In this aspect, the European Union (EU) implemented better data protection measures and guided the government and various entities on the acceptable ways of handling data during a pandemic, though the measures taken were not very comprehensive. Canadian privacy laws in general are sector driven and not harmonised at the national level and there is no new guidance on the usage of data during emergencies. Hence, this research will analyse laws and regulation in EU and Canada with a view to understanding the necessity of amending privacy laws in Canada to make it relevant, up-to-date and in compliance with EU data protection requirements so data sharing from EU countries could be made easy. It further encapsulates appropriate standards for Canada health data protection for better management of health data privacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.